We are live on ! Find out more
PAM

PVG Asset Management Portfolio holdings

AUM $173M
1-Year Est. Return 64.51%
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
+64.51%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.1M
AUM Growth
-$3.75M
Cap. Flow
-$3.7M
Cap. Flow %
-17.49%
Top 10 Hldgs %
42.97%
Holding
72
New
28
Increased
7
Reduced
10
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 30.35%
2 Technology 15.47%
3 Consumer Discretionary 4.64%
4 Real Estate 4.4%
5 Consumer Staples 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BXMX
1
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$1.28M 6.05%
+91,460
New +$1.27M
VOO icon
2
Vanguard S&P 500 ETF
VOO
$964B
$1.2M 5.67%
2,226
-288
-11% -$156K
SH icon
3
ProShares Short S&P500
SH
$920M
$1.05M 4.98%
+24,859
New +$1.06M
IVV icon
4
iShares Core S&P 500 ETF
IVV
$865B
$994K 4.7%
1,688
-183
-10% -$108K
AVXL icon
5
Anavex Life Sciences
AVXL
$232M
$843K 3.99%
78,490
+65,485
+504% +$504K
NVDA icon
6
NVIDIA
NVDA
$4.67T
$834K 3.94%
+6,207
New +$856K
FBIO icon
7
Fortress Biotech
FBIO
$112M
$782K 3.7%
386,295
+12,505
+3% +$22.7K
AMZN icon
8
Amazon
AMZN
$2.48T
$743K 3.51%
+3,386
New +$693K
VERU icon
9
Veru
VERU
$35.3M
$681K 3.22%
104,731
+41,034
+64% +$304K
PFE icon
10
Pfizer
PFE
$144B
$673K 3.19%
+25,379
New +$688K
AAPL icon
11
Apple
AAPL
$5.02T
$672K 3.18%
+2,685
New +$633K
DERM icon
12
Journey Medical
DERM
$171M
$657K 3.11%
168,105
+560
+0.3% +$3.06K
CRDL
13
Cardiol Therapeutics
CRDL
$135M
$624K 2.95%
+487,295
New +$822K
IWM icon
14
iShares Russell 2000 ETF
IWM
$79.4B
$568K 2.69%
2,571
+939
+58% +$214K
BIL icon
15
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$547K 2.59%
5,982
-40,743
-87% -$3.73M
MSFT icon
16
Microsoft
MSFT
$2.94T
$542K 2.56%
+1,286
New +$548K
AVGO icon
17
Broadcom
AVGO
$1.79T
$540K 2.56%
+2,330
New +$431K
SDS icon
18
ProShares UltraShort S&P500
SDS
$428M
$501K 2.37%
5,092
-29,625
-85% -$2.93M
DX
19
Dynex Capital
DX
$3.19B
$500K 2.36%
39,496
-34,384
-47% -$429K
ABBV icon
20
AbbVie
ABBV
$470B
$425K 2.01%
+2,391
New +$440K
GRAL
21
GRAIL Inc
GRAL
$2.71B
$398K 1.88%
22,287
-11,110
-33% -$181K
CKPT
22
DELISTED
Checkpoint Therapeutics
CKPT
$395K 1.87%
123,475
-26,395
-18% -$89.5K
FTHY
23
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$500M
$388K 1.83%
+26,770
New +$394K
AXON
24
Axon Enterprise
AXON
$44.4B
$386K 1.83%
+650
New +$354K
GOOG icon
25
Alphabet (Google) Class C
GOOG
$4.11T
$386K 1.83%
2,027
-157
-7% -$27.7K

Similar funds

PVG Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, PVG Asset Management held 72 positions worth $21.1M, down 15% from $24.9M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PVG Asset Management withdrew a net $3.7M in Q4 2024, closing 26 positions and reducing 10 holdings. Its most notable exit was APA Corp, an estimated $757K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PVG Asset Management opened a new position in Nuveen S&P 500 Buy-Write Income Fund worth $1.28M.

  • PVG Asset Management's largest Q4 2024 buy was Nuveen S&P 500 Buy-Write Income Fund: 91,460 shares worth $1.28M.
  • PVG Asset Management added most to Anavex Life Sciences in Q4 2024, an estimated $504K increase.
  • PVG Asset Management's biggest Q4 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $3.73M.
  • PVG Asset Management fully exited APA Corp in Q4 2024, selling an estimated $757K.
  • PVG Asset Management's ten largest holdings make up 43% of its $21.1M portfolio in Q4 2024.
  • PVG Asset Management opened 28 new positions and closed 26 in Q4 2024.
  • PVG Asset Management's portfolio value fell 15% quarter-over-quarter to $21.1M.

Based on PVG Asset Management's 13F filing for Q4 2024, filed 21 Feb 2025.